about
Physiological characterisation of human iPS-derived dopaminergic neuronsA rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infectionProteomic-based identification of CD4-interacting proteins in human primary macrophagesTransportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration.Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery.Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion.A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation.An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction.Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics.Generation of neutralizing aptamers against herpes simplex virus type 2: potential components of multivalent microbicides.CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells.The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-SeqDifferentially expressed, variant U1 snRNAs regulate gene expression in human cellsProtein kinase C and NF-κB-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: consequences for HIV-1 infectionDerivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous diseaseER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.A novel real time imaging platform to quantify macrophage phagocytosisVariant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages.Structural characterization of a 2'F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120.PCR and the cloning of receptor subtype genes.The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4.HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use.Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes.LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.Episomal transgene expression in pluripotent stem cells.Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells.Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.Molecular epidemiology of dengue virus type 3 in Venezuela.Heterokaryons formed between a rat myeloma and a mouse fibroblast are permissive for entry of HIV type 1.A rodent cell line permissive for entry and reverse transcription of human immunodeficiency virus type 1 has a pre-integration block to productive infection.Excess α-synuclein compromises phagocytosis in iPSC-derived macrophagesInhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides.The 5' leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties.Conformational pH dependence of intermediate states during oligomerization of the human prion protein.Host-adaptive antigenic variation in Bunyaviruses.
P50
Q27324718-B3B16E2D-2E92-4670-B914-D2FA6B8B46ABQ27485098-B956665C-E36B-4018-B7B2-AF7B93823B90Q28477747-07409207-11A2-4AA2-9CE6-B60F63ADAEEAQ30406846-A15D1EC1-C9D4-4DDD-9241-6D59D88656D3Q30787547-ECCB8A28-0E31-43F0-86EA-92297CC173CEQ31151988-58FC4090-9F3D-492C-AE14-FFB4423401EDQ33796396-E503A312-01C5-4A29-94E7-C2534ECD48F6Q34088355-067BAFF0-AE06-4983-ACA5-D36FF68A802FQ34092668-0BCA111E-C03C-40A4-AC37-E3D28051F59AQ34366417-F53F9036-8AC4-41F9-AF28-85E6633CB805Q34509294-6D521B51-5314-4E14-8808-79215E3295CEQ35199134-F2606EB3-7A84-4544-8482-A752E1A12BB0Q36130564-F4C78147-9772-4ACE-8780-7234BBF3CBABQ36243217-CA182FD3-079E-49C6-9ABA-689F0F368895Q36580574-4A694F30-7B6B-424C-B242-4BB129DC7C5BQ36655072-E4C546D0-B000-4786-8375-71BA9D031FE9Q36670949-49BE0833-4EAA-4DF3-8769-A976BB3EE9D1Q36678823-E45D003E-71B9-4151-BD46-C05ECF315673Q37235303-4232CCE3-64B6-4A5D-A0F8-57E61ADA0591Q37507550-DA7C4F01-0499-46DE-BF84-0A068F4EB8EAQ37644726-CF13A6A6-F891-404E-81D4-08EBC76E7B81Q38288521-EDCCA1E1-FD84-47A5-A07D-6777E79AC7F4Q38313647-B379A538-6693-4AD8-9816-031F7AAC74C5Q39030295-D84573E2-74E8-48C0-9331-BF35EBC61EC9Q39032916-CB880F03-593F-4503-A4B5-D8F40C084A3FQ39091904-0D531EAB-7E90-4E7D-8A98-60C50C7142FBQ39137339-51E41B6D-41A6-42EC-863F-919E8414E6E1Q39493640-EC795FDE-DF72-4441-B9F0-C83D15857DF3Q39540191-DD1F377B-18F7-4281-A235-4846F2C3BAFDQ40413014-EC1A3D46-7604-4022-AEB6-B3552FA6D41DQ40558233-9069B19D-1F5A-4EFB-9342-2495BD910CFBQ41419623-5A2D451A-6DC0-43C8-A2B3-A439C06A5495Q41440939-A5A1B3B8-AD48-48C9-A3F5-6F20F86CC8AFQ41488989-C3F5FDC4-B7EC-4017-BBFE-37916EDE45B5Q41723140-9899D6D2-6512-4281-9189-A320E3AD7BC9Q41760887-87A5E268-25F8-4769-9280-F87A87CBE848Q41925530-21BF9A84-BF0D-49EA-9FAE-E5FA2EA45CD6Q41950007-D3D088F6-F1D3-4E5E-9B85-3EA67B5D2F30Q41993451-0C7FD5DA-AC8F-4920-8E55-401A77C82671Q42988834-438BBE16-67A3-4737-82F5-FB2AE83EE4C4
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-2506-1198
@en
name
William James
@ast
William James
@en
William James
@es
William James
@nl
type
label
William James
@ast
William James
@en
William James
@es
William James
@nl
prefLabel
William James
@ast
William James
@en
William James
@es
William James
@nl
P106
P1153
35479049300
P31
P496
0000-0002-2506-1198